<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-03-07" modified="2018-01-31" version="123">
<accession>Q3T906</accession>
<accession>A2RRQ9</accession>
<accession>Q3ZQK2</accession>
<accession>Q6IPW5</accession>
<accession>Q86TQ2</accession>
<accession>Q96N13</accession>
<accession>Q9ULL2</accession>
<name>GNPTA_HUMAN</name>
<protein>
<recommendedName>
<fullName>N-acetylglucosamine-1-phosphotransferase subunits alpha/beta</fullName>
<ecNumber evidence="17">2.7.8.17</ecNumber>
</recommendedName>
<alternativeName>
<fullName>GlcNAc-1-phosphotransferase subunits alpha/beta</fullName>
</alternativeName>
<alternativeName>
<fullName>Stealth protein GNPTAB</fullName>
</alternativeName>
<alternativeName>
<fullName>UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>N-acetylglucosamine-1-phosphotransferase subunit alpha</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>N-acetylglucosamine-1-phosphotransferase subunit beta</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">GNPTAB</name>
<name type="synonym">GNPTA</name>
<name type="synonym">KIAA1208</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2005" name="Nat. Med." volume="11" first="1109" last="1112">
<title>Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase.</title>
<authorList>
<person name="Tiede S."/>
<person name="Storch S."/>
<person name="Luebke T."/>
<person name="Henrissat B."/>
<person name="Bargal R."/>
<person name="Raas-Rothschild A."/>
<person name="Braulke T."/>
</authorList>
<dbReference type="PubMed" id="16200072"/>
<dbReference type="DOI" id="10.1038/nm1305"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INVOLVEMENT IN MLII</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="36141" last="36149">
<title>The alpha- and beta-subunits of the human UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase are encoded by a single cDNA.</title>
<authorList>
<person name="Kudo M."/>
<person name="Bao M."/>
<person name="D'Souza A."/>
<person name="Ying F."/>
<person name="Pan H."/>
<person name="Roe B.A."/>
<person name="Canfield W.M."/>
</authorList>
<dbReference type="PubMed" id="16120602"/>
<dbReference type="DOI" id="10.1074/jbc.M509008200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="42476" last="42476">
<authorList>
<person name="Kudo M."/>
<person name="Bao M."/>
<person name="D'Souza A."/>
<person name="Ying F."/>
<person name="Pan H."/>
<person name="Roe B.A."/>
<person name="Canfield W.M."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-847 (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="DNA Res." volume="6" first="337" last="345">
<title>Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Kikuno R."/>
<person name="Hirosawa M."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10574462"/>
<dbReference type="DOI" id="10.1093/dnares/6.5.337"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 307-1256 (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="DNA Res." volume="9" first="99" last="106">
<title>Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Okazaki N."/>
<person name="Yamakawa H."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
</authorList>
<dbReference type="PubMed" id="12168954"/>
<dbReference type="DOI" id="10.1093/dnares/9.3.99"/>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="PLoS Comput. Biol." volume="1" first="492" last="499">
<title>Stealth proteins: in silico identification of a novel protein family rendering bacterial pathogens invisible to host immune defense.</title>
<authorList>
<person name="Sperisen P."/>
<person name="Schmid C.D."/>
<person name="Bucher P."/>
<person name="Zilian O."/>
</authorList>
<dbReference type="PubMed" id="16299590"/>
<dbReference type="DOI" id="10.1371/journal.pcbi.0010063"/>
</citation>
<scope>IDENTIFICATION AS A STEALTH PROTEIN</scope>
<scope>PUTATIVE FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-699</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="3360" last="3370">
<title>Functions of the alpha, beta, and gamma subunits of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase.</title>
<authorList>
<person name="Qian Y."/>
<person name="Lee I."/>
<person name="Lee W.S."/>
<person name="Qian M."/>
<person name="Kudo M."/>
<person name="Canfield W.M."/>
<person name="Lobel P."/>
<person name="Kornfeld S."/>
</authorList>
<dbReference type="PubMed" id="19955174"/>
<dbReference type="DOI" id="10.1074/jbc.M109.068650"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Science" volume="333" first="87" last="90">
<title>A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism.</title>
<authorList>
<person name="Marschner K."/>
<person name="Kollmann K."/>
<person name="Schweizer M."/>
<person name="Braulke T."/>
<person name="Pohl S."/>
</authorList>
<dbReference type="PubMed" id="21719679"/>
<dbReference type="DOI" id="10.1126/science.1205677"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
<scope>MUTAGENESIS OF ARG-925; LEU-927 AND LYS-928</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="Genomics" volume="102" first="169" last="173">
<title>Two homozygous nonsense mutations of GNPTAB gene in two Chinese families with mucolipidosis II alpha/beta using targeted next-generation sequencing.</title>
<authorList>
<person name="Yang Y."/>
<person name="Wu J."/>
<person name="Liu H."/>
<person name="Chen X."/>
<person name="Wang Y."/>
<person name="Zhao M."/>
<person name="He X."/>
</authorList>
<dbReference type="PubMed" id="23773965"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2013.06.001"/>
</citation>
<scope>INVOLVEMENT IN MLII</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="3532" last="3537">
<title>Mislocalization of phosphotransferase as a cause of mucolipidosis III alphabeta.</title>
<authorList>
<person name="van Meel E."/>
<person name="Qian Y."/>
<person name="Kornfeld S.A."/>
</authorList>
<dbReference type="PubMed" id="24550498"/>
<dbReference type="DOI" id="10.1073/pnas.1401417111"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS MLIIIA GLN-4 AND TYR-15</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="3045" last="3056">
<title>Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.</title>
<authorList>
<person name="Qian Y."/>
<person name="van Meel E."/>
<person name="Flanagan-Steet H."/>
<person name="Yox A."/>
<person name="Steet R."/>
<person name="Kornfeld S."/>
</authorList>
<dbReference type="PubMed" id="25505245"/>
<dbReference type="DOI" id="10.1074/jbc.M114.612507"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS MLII LEU-81; ASP-182; PRO-205; LEU-334; LEU-348; LEU-374; ASN-732; ARG-928; VAL-955; CYS-986; PRO-1001; VAL-1054 AND MET-1236</scope>
<scope>CHARACTERIZATION OF VARIANTS MLIIIA GLN-4; TYR-15; VAL-190; GLN-334; PHE-399; THR-403; ALA-407; TYR-442; GLY-461; SER-468; TYR-505; PRO-587; PRO-926; TYR-956; GLY-1018 AND SER-1153</scope>
<scope>CHARACTERIZATION OF VARIANTS ARG-523; THR-592 AND TRP-785</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Am. J. Med. Genet. A" volume="137" first="235" last="240">
<title>Missense mutations in N-acetylglucosamine-1-phosphotransferase alpha/beta subunit gene in a patient with mucolipidosis III and a mild clinical phenotype.</title>
<authorList>
<person name="Tiede S."/>
<person name="Muschol N."/>
<person name="Reutter G."/>
<person name="Cantz M."/>
<person name="Ullrich K."/>
<person name="Braulke T."/>
</authorList>
<dbReference type="PubMed" id="16094673"/>
<dbReference type="DOI" id="10.1002/ajmg.a.30868"/>
</citation>
<scope>VARIANT MLIIIA ALA-407</scope>
<scope>VARIANT GLY-662</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Am. J. Hum. Genet." volume="78" first="451" last="463">
<title>Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-Hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha/beta-subunits precursor gene.</title>
<authorList>
<person name="Kudo M."/>
<person name="Brem M.S."/>
<person name="Canfield W.M."/>
</authorList>
<dbReference type="PubMed" id="16465621"/>
<dbReference type="DOI" id="10.1086/500849"/>
</citation>
<scope>VARIANT MLIIIA GLN-4</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Hum. Mutat." volume="27" first="830" last="831">
<title>Missense mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTA) in a patient with mucolipidosis II induces changes in the size and cellular distribution of GNPTG.</title>
<authorList>
<person name="Tiede S."/>
<person name="Cantz M."/>
<person name="Spranger J."/>
<person name="Braulke T."/>
</authorList>
<dbReference type="PubMed" id="16835905"/>
<dbReference type="DOI" id="10.1002/humu.9443"/>
</citation>
<scope>VARIANT MLII MET-1236</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Mol. Genet. Metab." volume="88" first="359" last="363">
<title>When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients.</title>
<authorList>
<person name="Bargal R."/>
<person name="Zeigler M."/>
<person name="Abu-Libdeh B."/>
<person name="Zuri V."/>
<person name="Mandel H."/>
<person name="Ben Neriah Z."/>
<person name="Stewart F."/>
<person name="Elcioglu N."/>
<person name="Hindi T."/>
<person name="Le Merrer M."/>
<person name="Bach G."/>
<person name="Raas-Rothschild A."/>
</authorList>
<dbReference type="PubMed" id="16630736"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2006.03.003"/>
</citation>
<scope>VARIANT MLIIIA PHE-399</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Clin. Chim. Acta" volume="376" first="250" last="252">
<title>DNA-based diagnosis of mucolipidosis type IIIA and mucopolysacchariodisis type VI in a Chinese family: a chance of 1 in 7.6 trillion.</title>
<authorList>
<person name="Lam C.W."/>
<person name="Yan M.S."/>
<person name="Li C.K."/>
<person name="Lau K.C."/>
<person name="Tong S.F."/>
<person name="Tang H.Y."/>
</authorList>
<dbReference type="PubMed" id="17034777"/>
<dbReference type="DOI" id="10.1016/j.cca.2006.09.004"/>
</citation>
<scope>VARIANT MLIIIA PRO-587</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Am. J. Med. Genet. A" volume="149A" first="2753" last="2761">
<title>Molecular analysis of cell lines from patients with mucolipidosis II and mucolipidosis III.</title>
<authorList>
<person name="Zarghooni M."/>
<person name="Dittakavi S.S."/>
</authorList>
<dbReference type="PubMed" id="19938078"/>
<dbReference type="DOI" id="10.1002/ajmg.a.33134"/>
</citation>
<scope>VARIANTS MLII ASP-182; PRO-205; ASN-732; ARG-928; VAL-955 AND VAL-1054</scope>
<scope>VARIANT MLIIIA GLN-4</scope>
<scope>CHARACTERIZATION OF VARIANT MLIIIA GLN-4</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Hum. Mutat." volume="30" first="E956" last="E973">
<title>Molecular characterization of 22 novel UDP-N-acetylglucosamine-1-phosphate transferase alpha- and beta-subunit (GNPTAB) gene mutations causing mucolipidosis types IIalpha/beta and IIIalpha/beta in 46 patients.</title>
<authorList>
<person name="Tappino B."/>
<person name="Chuzhanova N.A."/>
<person name="Regis S."/>
<person name="Dardis A."/>
<person name="Corsolini F."/>
<person name="Stroppiano M."/>
<person name="Tonoli E."/>
<person name="Beccari T."/>
<person name="Rosano C."/>
<person name="Mucha J."/>
<person name="Blanco M."/>
<person name="Szlago M."/>
<person name="Di Rocco M."/>
<person name="Cooper D.N."/>
<person name="Filocamo M."/>
</authorList>
<dbReference type="PubMed" id="19634183"/>
<dbReference type="DOI" id="10.1002/humu.21099"/>
</citation>
<scope>VARIANTS MLIIIA THR-403; TYR-442; GLY-461 AND PRO-926</scope>
<scope>VARIANT MLII PRO-1001</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="J. Hum. Genet." volume="54" first="145" last="151">
<title>Mucolipidosis II and III alpha/beta: mutation analysis of 40 Japanese patients showed genotype-phenotype correlation.</title>
<authorList>
<person name="Otomo T."/>
<person name="Muramatsu T."/>
<person name="Yorifuji T."/>
<person name="Okuyama T."/>
<person name="Nakabayashi H."/>
<person name="Fukao T."/>
<person name="Ohura T."/>
<person name="Yoshino M."/>
<person name="Tanaka A."/>
<person name="Okamoto N."/>
<person name="Inui K."/>
<person name="Ozono K."/>
<person name="Sakai N."/>
</authorList>
<dbReference type="PubMed" id="19197337"/>
<dbReference type="DOI" id="10.1038/jhg.2009.3"/>
</citation>
<scope>VARIANTS MLII LEU-334 AND LEU-374</scope>
<scope>VARIANTS MLIIIA LEU-374; TYR-956 AND SER-1153</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="J. Med. Genet." volume="47" first="38" last="48">
<title>Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands.</title>
<authorList>
<person name="Cathey S.S."/>
<person name="Leroy J.G."/>
<person name="Wood T."/>
<person name="Eaves K."/>
<person name="Simensen R.J."/>
<person name="Kudo M."/>
<person name="Stevenson R.E."/>
<person name="Friez M.J."/>
</authorList>
<dbReference type="PubMed" id="19617216"/>
<dbReference type="DOI" id="10.1136/jmg.2009.067736"/>
</citation>
<scope>VARIANTS MLIIIA GLN-4; TYR-15; VAL-190; GLN-334; PHE-399; SER-468; TYR-505; ARG-956 AND GLY-1018</scope>
<scope>VARIANT MLII LEU-348</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="N. Engl. J. Med." volume="362" first="677" last="685">
<title>Mutations in the lysosomal enzyme-targeting pathway and persistent stuttering.</title>
<authorList>
<person name="Kang C."/>
<person name="Riazuddin S."/>
<person name="Mundorff J."/>
<person name="Krasnewich D."/>
<person name="Friedman P."/>
<person name="Mullikin J.C."/>
<person name="Drayna D."/>
</authorList>
<dbReference type="PubMed" id="20147709"/>
<dbReference type="DOI" id="10.1056/NEJMoa0902630"/>
</citation>
<scope>VARIANTS SER-455; LEU-625 AND LYS-1200</scope>
<scope>POSSIBLE INVOLVEMENT IN PERSISTENT STUTTERING</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="Am. J. Med. Genet. A" volume="158A" first="1225" last="1228">
<title>Mucolipidosis type II alpha/beta with a homozygous missense mutation in the GNPTAB gene.</title>
<authorList>
<person name="Coutinho M.F."/>
<person name="Santos L.S."/>
<person name="Girisha K.M."/>
<person name="Satyamoorthy K."/>
<person name="Lacerda L."/>
<person name="Prata M.J."/>
<person name="Alves S."/>
</authorList>
<dbReference type="PubMed" id="22495880"/>
<dbReference type="DOI" id="10.1002/ajmg.a.35295"/>
</citation>
<scope>VARIANT MLII CYS-986</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Eur. J. Hum. Genet." volume="22" first="594" last="601">
<title>A novel intermediate mucolipidosis II/IIIalphabeta caused by GNPTAB mutation in the cytosolic N-terminal domain.</title>
<authorList>
<person name="Leroy J.G."/>
<person name="Sillence D."/>
<person name="Wood T."/>
<person name="Barnes J."/>
<person name="Lebel R.R."/>
<person name="Friez M.J."/>
<person name="Stevenson R.E."/>
<person name="Steet R."/>
<person name="Cathey S.S."/>
</authorList>
<dbReference type="PubMed" id="24045841"/>
<dbReference type="DOI" id="10.1038/ejhg.2013.207"/>
</citation>
<scope>VARIANT MLIIIA GLN-4</scope>
<scope>CHARACTERIZATION OF VARIANT MLIIIA GLN-4</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="Gene" volume="524" first="59" last="64">
<title>Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene.</title>
<authorList>
<person name="Cury G.K."/>
<person name="Matte U."/>
<person name="Artigalas O."/>
<person name="Alegra T."/>
<person name="Velho R.V."/>
<person name="Sperb F."/>
<person name="Burin M.G."/>
<person name="Ribeiro E.M."/>
<person name="Lourenco C.M."/>
<person name="Kim C.A."/>
<person name="Valadares E.R."/>
<person name="Galera M.F."/>
<person name="Acosta A.X."/>
<person name="Schwartz I.V."/>
</authorList>
<dbReference type="PubMed" id="23566849"/>
<dbReference type="DOI" id="10.1016/j.gene.2013.03.105"/>
</citation>
<scope>VARIANT MLII LEU-81</scope>
<scope>VARIANTS MLIIIA PHE-399; THR-403 AND TYR-505</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="Hum. Mutat." volume="35" first="368" last="376">
<title>Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB).</title>
<authorList>
<person name="De Pace R."/>
<person name="Coutinho M.F."/>
<person name="Koch-Nolte F."/>
<person name="Haag F."/>
<person name="Prata M.J."/>
<person name="Alves S."/>
<person name="Braulke T."/>
<person name="Pohl S."/>
</authorList>
<dbReference type="PubMed" id="24375680"/>
<dbReference type="DOI" id="10.1002/humu.22502"/>
</citation>
<scope>VARIANTS MLII LEU-81; CYS-986 AND MET-1236</scope>
<scope>VARIANT MLIIIA PHE-399</scope>
<scope>CHARACTERIZATION OF VARIANTS MLII LEU-81; CYS-986 AND MET-1236</scope>
<scope>CHARACTERIZATION OF VARIANT MLIIIA PHE-399</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="10246" last="10251">
<title>The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is a substrate recognition module.</title>
<authorList>
<person name="Qian Y."/>
<person name="Flanagan-Steet H."/>
<person name="van Meel E."/>
<person name="Steet R."/>
<person name="Kornfeld S.A."/>
</authorList>
<dbReference type="PubMed" id="23733939"/>
<dbReference type="DOI" id="10.1073/pnas.1308453110"/>
</citation>
<scope>VARIANT MLII ASN-732</scope>
<scope>CHARACTERIZATION OF VARIANT MLII ASN-732</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="Orphanet J. Rare Dis." volume="9" first="59" last="59">
<title>Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders.</title>
<authorList>
<person name="Fernandez-Marmiesse A."/>
<person name="Morey M."/>
<person name="Pineda M."/>
<person name="Eiris J."/>
<person name="Couce M.L."/>
<person name="Castro-Gago M."/>
<person name="Fraga J.M."/>
<person name="Lacerda L."/>
<person name="Gouveia S."/>
<person name="Perez-Poyato M.S."/>
<person name="Armstrong J."/>
<person name="Castineiras D."/>
<person name="Cocho J.A."/>
</authorList>
<dbReference type="PubMed" id="24767253"/>
<dbReference type="DOI" id="10.1186/1750-1172-9-59"/>
</citation>
<scope>VARIANTS THR-592 AND TRP-785</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="Hum. Mol. Genet." volume="24" first="3497" last="3505">
<title>Analyses of disease-related GNPTAB mutations define a novel GlcNAc-1-phosphotransferase interaction domain and an alternative site-1 protease cleavage site.</title>
<authorList>
<person name="Velho R.V."/>
<person name="De Pace R."/>
<person name="Kluender S."/>
<person name="Sperb-Ludwig F."/>
<person name="Lourenco C.M."/>
<person name="Schwartz I.V."/>
<person name="Braulke T."/>
<person name="Pohl S."/>
</authorList>
<dbReference type="PubMed" id="25788519"/>
<dbReference type="DOI" id="10.1093/hmg/ddv100"/>
</citation>
<scope>VARIANTS MLIIIA MET-644 AND THR-1223 DEL</scope>
<scope>CHARACTERIZATION OF VARIANTS MLIIIA PHE-399; THR-403; TYR-505; ARG-575; MET-644 AND THR-1223 DEL</scope>
<scope>CHARACTERIZATION OF VARIANT MLII 937-TYR--MET-972 DEL</scope>
<scope>MUTAGENESIS OF ILE-346 AND TRP-357</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2015" name="JIMD Rep." volume="15" first="123" last="132">
<title>Dried blood spots allow targeted screening to diagnose mucopolysaccharidosis and mucolipidosis.</title>
<authorList>
<person name="Cobos P.N."/>
<person name="Steglich C."/>
<person name="Santer R."/>
<person name="Lukacs Z."/>
<person name="Gal A."/>
</authorList>
<dbReference type="PubMed" id="24798265"/>
<dbReference type="DOI" id="10.1007/8904_2014_308"/>
</citation>
<scope>VARIANT MLII CYS-986</scope>
<scope>VARIANT ARG-523</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2016" name="Nature" volume="536" first="285" last="291">
<title>Analysis of protein-coding genetic variation in 60,706 humans.</title>
<authorList>
<consortium name="Exome Aggregation Consortium"/>
<person name="Lek M."/>
<person name="Karczewski K.J."/>
<person name="Minikel E.V."/>
<person name="Samocha K.E."/>
<person name="Banks E."/>
<person name="Fennell T."/>
<person name="O'Donnell-Luria A.H."/>
<person name="Ware J.S."/>
<person name="Hill A.J."/>
<person name="Cummings B.B."/>
<person name="Tukiainen T."/>
<person name="Birnbaum D.P."/>
<person name="Kosmicki J.A."/>
<person name="Duncan L.E."/>
<person name="Estrada K."/>
<person name="Zhao F."/>
<person name="Zou J."/>
<person name="Pierce-Hoffman E."/>
<person name="Berghout J."/>
<person name="Cooper D.N."/>
<person name="Deflaux N."/>
<person name="DePristo M."/>
<person name="Do R."/>
<person name="Flannick J."/>
<person name="Fromer M."/>
<person name="Gauthier L."/>
<person name="Goldstein J."/>
<person name="Gupta N."/>
<person name="Howrigan D."/>
<person name="Kiezun A."/>
<person name="Kurki M.I."/>
<person name="Moonshine A.L."/>
<person name="Natarajan P."/>
<person name="Orozco L."/>
<person name="Peloso G.M."/>
<person name="Poplin R."/>
<person name="Rivas M.A."/>
<person name="Ruano-Rubio V."/>
<person name="Rose S.A."/>
<person name="Ruderfer D.M."/>
<person name="Shakir K."/>
<person name="Stenson P.D."/>
<person name="Stevens C."/>
<person name="Thomas B.P."/>
<person name="Tiao G."/>
<person name="Tusie-Luna M.T."/>
<person name="Weisburd B."/>
<person name="Won H.H."/>
<person name="Yu D."/>
<person name="Altshuler D.M."/>
<person name="Ardissino D."/>
<person name="Boehnke M."/>
<person name="Danesh J."/>
<person name="Donnelly S."/>
<person name="Elosua R."/>
<person name="Florez J.C."/>
<person name="Gabriel S.B."/>
<person name="Getz G."/>
<person name="Glatt S.J."/>
<person name="Hultman C.M."/>
<person name="Kathiresan S."/>
<person name="Laakso M."/>
<person name="McCarroll S."/>
<person name="McCarthy M.I."/>
<person name="McGovern D."/>
<person name="McPherson R."/>
<person name="Neale B.M."/>
<person name="Palotie A."/>
<person name="Purcell S.M."/>
<person name="Saleheen D."/>
<person name="Scharf J.M."/>
<person name="Sklar P."/>
<person name="Sullivan P.F."/>
<person name="Tuomilehto J."/>
<person name="Tsuang M.T."/>
<person name="Watkins H.C."/>
<person name="Wilson J.G."/>
<person name="Daly M.J."/>
<person name="MacArthur D.G."/>
</authorList>
<dbReference type="PubMed" id="27535533"/>
<dbReference type="DOI" id="10.1038/nature19057"/>
</citation>
<scope>VARIANT LYS-1200</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="Int. J. Biochem. Cell Biol." volume="92" first="90" last="94">
<title>GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II through distinct mechanisms.</title>
<authorList>
<person name="Ludwig N.F."/>
<person name="Velho R.V."/>
<person name="Sperb-Ludwig F."/>
<person name="Acosta A.X."/>
<person name="Ribeiro E.M."/>
<person name="Kim C.A."/>
<person name="Gandelman Horovitz D.D."/>
<person name="Boy R."/>
<person name="Rodovalho-Doriqui M.J."/>
<person name="Lourenco C.M."/>
<person name="Santos E.S."/>
<person name="Braulke T."/>
<person name="Pohl S."/>
<person name="Schwartz I.V.D."/>
</authorList>
<dbReference type="PubMed" id="28918368"/>
<dbReference type="DOI" id="10.1016/j.biocel.2017.09.006"/>
</citation>
<scope>VARIANTS MLII GLY-76; LEU-81; LEU-385 AND 1111-TYR--VAL-1256 DEL</scope>
<scope>CHARACTERIZATION OF VARIANTS MLII GLY-76 AND LEU-385</scope>
<scope>VARIANTS MLIIIA LEU-81; 278-GLN--VAL-1256 DEL; THR-403 AND TYR-505</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<comment type="function">
<text evidence="17 22 32">Catalyzes the formation of mannose 6-phosphate (M6P) markers on high mannose type oligosaccharides in the Golgi apparatus. M6P residues are required to bind to the M6P receptors (MPR), which mediate the vesicular transport of lysosomal enzymes to the endosomal/prelysosomal compartment.</text>
</comment>
<comment type="catalytic activity">
<text evidence="17">UDP-N-acetyl-D-glucosamine + lysosomal-enzyme D-mannose = UMP + lysosomal-enzyme N-acetyl-D-glucosaminyl-phospho-D-mannose.</text>
</comment>
<comment type="subunit">
<text evidence="17">Hexamer of two alpha, two beta and two gamma (GNPTG) subunits; disulfide-linked. The alpha and/or the beta subunits of the enzyme constitute the catalytic subunits.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1104907"/>
<interactant intactId="EBI-8637627">
<id>Q8WTP8</id>
<label>AEN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1104907"/>
<interactant intactId="EBI-6658203">
<id>Q86YD7</id>
<label>FAM90A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1104907"/>
<interactant intactId="EBI-359352">
<id>P25786</id>
<label>PSMA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1104907"/>
<interactant intactId="EBI-745021">
<id>Q96FJ0</id>
<label>STAMBPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1104907"/>
<interactant intactId="EBI-10177272">
<id>P15622-3</id>
<label>ZNF250</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>N-acetylglucosamine-1-phosphotransferase subunit alpha</molecule>
<subcellularLocation>
<location evidence="6 7 19 22 25 30 32">Golgi apparatus membrane</location>
<topology evidence="34">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>N-acetylglucosamine-1-phosphotransferase subunit beta</molecule>
<subcellularLocation>
<location evidence="6 7 19 22 25 32">Golgi apparatus membrane</location>
<topology evidence="34">Single-pass type II membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q3T906-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q3T906-2</id>
<name>2</name>
<sequence type="described" ref="VSP_017338 VSP_017339"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="6">Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.</text>
</comment>
<comment type="domain">
<text evidence="22">The DMAP-interaction domain mediates substrate recognition. It specifically recognizes a conformation-dependent protein determinant present in acid hydrolases (PubMed:23733939).</text>
</comment>
<comment type="PTM">
<text evidence="19 25 30 32">The alpha- and beta-subunits are generated by a proteolytic cleavage by MBTPS1 protease at the Lys-928-Asp-929 bond.</text>
</comment>
<comment type="disease" evidence="7 10 13 14 15 16 20 21 22 23 25 28 29 30 32">
<disease id="DI-01995">
<name>Mucolipidosis type II</name>
<acronym>MLII</acronym>
<description>Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth.</description>
<dbReference type="MIM" id="252500"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="5 8 9 11 13 14 15 16 21 24 25 26 29 30 32">
<disease id="DI-01996">
<name>Mucolipidosis type III complementation group A</name>
<acronym>MLIIIA</acronym>
<description>Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation.</description>
<dbReference type="MIM" id="252600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="18">Genetic variations in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech.</text>
</comment>
<comment type="miscellaneous">
<text>Due to the low pH in the endosomal/prelysosomal compartment, the lysosomal enzyme-MPR complex dissociates and then the enzyme is delivered to the lysosome. Between 5% and 20% of newly synthesized lysosomal enzymes escape the binding to the MPR in the Golgi apparatus and are secreted.</text>
</comment>
<comment type="miscellaneous">
<text>Stealth proteins are part of a protein family that is conserved from bacteria to higher eukaryotes. Family members were first identified in microbes as proteins that help pathogens to elude the host innate immune system. Microbial stealth proteins are most likely involved in the biosynthesis of exopolysaccharides. Stealth proteins are predicted to function as hexose-1-phosphoryltransferases.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the stealth family.</text>
</comment>
<dbReference type="EC" id="2.7.8.17" evidence="17"/>
<dbReference type="EMBL" id="AM085438">
<property type="protein sequence ID" value="CAJ30014.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY687932">
<property type="protein sequence ID" value="AAV98624.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC071687">
<property type="protein sequence ID" value="AAH71687.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC042615">
<property type="protein sequence ID" value="AAH42615.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC131787">
<property type="protein sequence ID" value="AAI31788.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK056137">
<property type="protein sequence ID" value="BAB71102.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB033034">
<property type="protein sequence ID" value="BAA86522.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9088.1">
<molecule id="Q3T906-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_077288.2">
<molecule id="Q3T906-1"/>
<property type="nucleotide sequence ID" value="NM_024312.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.46850"/>
<dbReference type="PDB" id="2N6D">
<property type="method" value="NMR"/>
<property type="chains" value="A=135-305"/>
</dbReference>
<dbReference type="PDBsum" id="2N6D"/>
<dbReference type="ProteinModelPortal" id="Q3T906"/>
<dbReference type="SMR" id="Q3T906"/>
<dbReference type="BioGrid" id="122576">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="CORUM" id="Q3T906"/>
<dbReference type="IntAct" id="Q3T906">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000299314"/>
<dbReference type="iPTMnet" id="Q3T906"/>
<dbReference type="PhosphoSitePlus" id="Q3T906"/>
<dbReference type="BioMuta" id="GNPTAB"/>
<dbReference type="DMDM" id="90185244"/>
<dbReference type="EPD" id="Q3T906"/>
<dbReference type="MaxQB" id="Q3T906"/>
<dbReference type="PaxDb" id="Q3T906"/>
<dbReference type="PeptideAtlas" id="Q3T906"/>
<dbReference type="PRIDE" id="Q3T906"/>
<dbReference type="Ensembl" id="ENST00000299314">
<molecule id="Q3T906-1"/>
<property type="protein sequence ID" value="ENSP00000299314"/>
<property type="gene ID" value="ENSG00000111670"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000549940">
<molecule id="Q3T906-2"/>
<property type="protein sequence ID" value="ENSP00000449150"/>
<property type="gene ID" value="ENSG00000111670"/>
</dbReference>
<dbReference type="GeneID" id="79158"/>
<dbReference type="KEGG" id="hsa:79158"/>
<dbReference type="UCSC" id="uc001tit.4">
<molecule id="Q3T906-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="79158"/>
<dbReference type="DisGeNET" id="79158"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000111670.14"/>
<dbReference type="GeneCards" id="GNPTAB"/>
<dbReference type="GeneReviews" id="GNPTAB"/>
<dbReference type="HGNC" id="HGNC:29670">
<property type="gene designation" value="GNPTAB"/>
</dbReference>
<dbReference type="HPA" id="HPA017754"/>
<dbReference type="HPA" id="HPA042343"/>
<dbReference type="MalaCards" id="GNPTAB"/>
<dbReference type="MIM" id="252500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="252600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607840">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q3T906"/>
<dbReference type="OpenTargets" id="ENSG00000111670"/>
<dbReference type="Orphanet" id="576">
<property type="disease" value="Mucolipidosis type 2"/>
</dbReference>
<dbReference type="Orphanet" id="577">
<property type="disease" value="Mucolipidosis type 3"/>
</dbReference>
<dbReference type="PharmGKB" id="PA128394710"/>
<dbReference type="eggNOG" id="ENOG410IEF9">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XYNB">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000006747"/>
<dbReference type="HOVERGEN" id="HBG057712"/>
<dbReference type="InParanoid" id="Q3T906"/>
<dbReference type="KO" id="K08239"/>
<dbReference type="OMA" id="FYESMFP"/>
<dbReference type="OrthoDB" id="EOG091G0C78"/>
<dbReference type="PhylomeDB" id="Q3T906"/>
<dbReference type="TreeFam" id="TF324175"/>
<dbReference type="BRENDA" id="2.7.8.17">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="ChiTaRS" id="GNPTAB">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="79158"/>
<dbReference type="PRO" id="PR:Q3T906"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000111670"/>
<dbReference type="CleanEx" id="HS_GNPTAB"/>
<dbReference type="ExpressionAtlas" id="Q3T906">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q3T906">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0003976">
<property type="term" value="F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046835">
<property type="term" value="P:carbohydrate phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007040">
<property type="term" value="P:lysosome organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016256">
<property type="term" value="P:N-glycan processing to lysosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033299">
<property type="term" value="P:secretion of lysosomal enzymes"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR010506">
<property type="entry name" value="DMAP1-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR018247">
<property type="entry name" value="EF_Hand_1_Ca_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002048">
<property type="entry name" value="EF_hand_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035993">
<property type="entry name" value="Notch-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000800">
<property type="entry name" value="Notch_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR031358">
<property type="entry name" value="Stealth_CR1"/>
</dbReference>
<dbReference type="InterPro" id="IPR021520">
<property type="entry name" value="Stealth_CR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR031357">
<property type="entry name" value="Stealth_CR3"/>
</dbReference>
<dbReference type="InterPro" id="IPR031356">
<property type="entry name" value="Stealth_CR4"/>
</dbReference>
<dbReference type="Pfam" id="PF06464">
<property type="entry name" value="DMAP_binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00066">
<property type="entry name" value="Notch"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF17101">
<property type="entry name" value="Stealth_CR1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11380">
<property type="entry name" value="Stealth_CR2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF17102">
<property type="entry name" value="Stealth_CR3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF17103">
<property type="entry name" value="Stealth_CR4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01137">
<property type="entry name" value="DMAP_binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00004">
<property type="entry name" value="NL"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF90193">
<property type="entry name" value="SSF90193"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00018">
<property type="entry name" value="EF_HAND_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50222">
<property type="entry name" value="EF_HAND_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50258">
<property type="entry name" value="LNR"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0942">Mucolipidosis</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="N-acetylglucosamine-1-phosphotransferase subunit alpha" id="PRO_0000225008">
<location>
<begin position="1"/>
<end position="928"/>
</location>
</feature>
<feature type="chain" description="N-acetylglucosamine-1-phosphotransferase subunit beta" id="PRO_0000225009">
<location>
<begin position="929"/>
<end position="1256"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="22"/>
<end position="42"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="1215"/>
<end position="1235"/>
</location>
</feature>
<feature type="repeat" description="LNR 1">
<location>
<begin position="438"/>
<end position="473"/>
</location>
</feature>
<feature type="repeat" description="LNR 2">
<location>
<begin position="505"/>
<end position="545"/>
</location>
</feature>
<feature type="domain" description="DMAP-interaction">
<location>
<begin position="700"/>
<end position="813"/>
</location>
</feature>
<feature type="domain" description="EF-hand" evidence="3">
<location>
<begin position="1005"/>
<end position="1040"/>
</location>
</feature>
<feature type="calcium-binding region" evidence="3">
<location>
<begin position="1018"/>
<end position="1029"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich">
<location>
<begin position="465"/>
<end position="498"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="4">
<location>
<position position="449"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="4">
<location>
<position position="464"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="4">
<location>
<position position="467"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="4">
<location>
<position position="516"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="4">
<location>
<position position="531"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="4">
<location>
<position position="534"/>
</location>
</feature>
<feature type="site" description="Cleavage; by MBTPS1">
<location>
<begin position="928"/>
<end position="929"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="83"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="114"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="148"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="179"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="250"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="614"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="699"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="729"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="829"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="1009"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="1129"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="438"/>
<end position="461"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="452"/>
<end position="468"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="505"/>
<end position="528"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="519"/>
<end position="535"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017338" evidence="33">
<original>NSGGSRYIAGGGGTGSIGVG</original>
<variation>KDVLNCNSFIFMEYFLLNHY</variation>
<location>
<begin position="471"/>
<end position="490"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017339" evidence="33">
<location>
<begin position="491"/>
<end position="1256"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; also found in patients with intermediate phenotype between MLII and MLIIIA; no effect on protein abundance; decreased retention in the Golgi; mistargeted to lysosomes and plasma membrane; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs34159654." id="VAR_027509" evidence="8 14 16 24 26 29">
<original>K</original>
<variation>Q</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; unknown pathological significance; no effect on protein abundance; decreased protein cleavage into alpha and beta subunits; decreased retention in the Golgi; mistargeted to lysosomes and plasma membrane; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281864947." id="VAR_073124" evidence="14 26 29">
<original>S</original>
<variation>Y</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; loss of Golgi localization; defects in protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity." id="VAR_079713" evidence="32">
<original>D</original>
<variation>G</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII and MLIIIA; no effect on protein abundance; decreased localization to the Golgi; defects in protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281864953." id="VAR_070831" evidence="21 25 29 32">
<original>W</original>
<variation>L</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; unknown pathological significance; decreased localization to the Golgi; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281864958." id="VAR_073125" evidence="16 29">
<original>V</original>
<variation>D</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; also found in patients with intermediate phenotype between MLII and MLIIIA; unknown pathological significance; no effect on protein abundance; no effect on localization to the Golgi; no effect on protein cleavage into alpha and beta subunits; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs34946266." id="VAR_053545" evidence="14">
<original>D</original>
<variation>V</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; unknown pathological significance; dbSNP:rs281864959." id="VAR_073126" evidence="16">
<original>Q</original>
<variation>P</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA." id="VAR_079714" evidence="32">
<location>
<begin position="278"/>
<end position="1256"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; no effect on protein abundance; loss of localization to the Golgi; loss of protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281864970." id="VAR_073127" evidence="13 29">
<original>R</original>
<variation>L</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on protein abundance; loss of localization to the Golgi; loss of protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281864970." id="VAR_073128" evidence="14 29">
<original>R</original>
<variation>Q</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; unknown pathological significance; no effect on protein abundance; no effect on localization to the Golgi; no effect on protein cleavage into alpha and beta subunits; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs7958709." id="VAR_027510" evidence="14 29">
<original>I</original>
<variation>L</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII and MLIIIA; no effect on protein abundance; no effect on localization to the Golgi; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs137852900." id="VAR_062807" evidence="13 29">
<original>F</original>
<variation>L</variation>
<location>
<position position="374"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; no loss of Golgi localization; no defects in protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity." id="VAR_079715" evidence="32">
<original>S</original>
<variation>L</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on protein abundance; loss of localization to the Golgi; defects in protein cleavage into alpha and beta subunits; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281865026." id="VAR_062808" evidence="9 14 21 25 29 30">
<original>S</original>
<variation>F</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; loss of localization to the Golgi; loss of protein cleavage into alpha and beta subunits; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281864973." id="VAR_062809" evidence="15 21 29 30 32">
<original>I</original>
<variation>T</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on protein abundance; no effect on localization to the Golgi; no effect on protein cleavage into alpha and beta subunits; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs137852895." id="VAR_025416" evidence="5 29">
<original>D</original>
<variation>A</variation>
<location>
<position position="407"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on localization to the Golgi; no effect on protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity toward some substrates; dbSNP:rs281864975." id="VAR_062810" evidence="15 29">
<original>C</original>
<variation>Y</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="sequence variant" description="Rare variant; found in individuals suffering from stuttering; unknown pathological significance; dbSNP:rs137853822." id="VAR_073219" evidence="18">
<original>A</original>
<variation>S</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on protein abundance; no effect on localization to the Golgi; no effect on protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity toward some substrates; dbSNP:rs281864977." id="VAR_062811" evidence="15 29">
<original>C</original>
<variation>G</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; patients with intermediate phenotype between MLII and MLIIIA; no effect on protein abundance; no effect on localization to the Golgi; no effect on protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity toward some substrates; dbSNP:rs281864979." id="VAR_073129" evidence="14 29">
<original>C</original>
<variation>S</variation>
<location>
<position position="468"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; unknown pathological significance; decreased localization to the Golgi; decreased protein cleavage into alpha and beta subunits; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; reduces protein abundance; dbSNP:rs281864980." id="VAR_070832" evidence="14 21 29 30 32">
<original>C</original>
<variation>Y</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with mucolipidosis type II or III; unknown pathological significance; decreased localization to the Golgi; decreased protein cleavage into alpha and beta subunits; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity." id="VAR_073130" evidence="28 29">
<original>C</original>
<variation>R</variation>
<location>
<position position="523"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; significantly reduces protein cleavage into alpha and beta subunits; reduces protein abundance; significantly decreased localization to the Golgi; significantly reduces UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase." id="VAR_074206" evidence="30">
<original>G</original>
<variation>R</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; decreased localization to the Golgi; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity." id="VAR_073131" evidence="11 29">
<original>R</original>
<variation>P</variation>
<location>
<position position="587"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with mucolipidosis type II or III; unknown pathological significance; decreased localization to the Golgi; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs149390820." id="VAR_073132" evidence="27 29">
<original>A</original>
<variation>T</variation>
<location>
<position position="592"/>
</location>
</feature>
<feature type="sequence variant" description="Rare variant; found in individuals suffering from stuttering; unknown pathological significance; dbSNP:rs137853823." id="VAR_073220" evidence="18">
<original>F</original>
<variation>L</variation>
<location>
<position position="625"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; reduces protein cleavage into alpha and beta subunits; reduces protein abundance; no effect on subcellular location in Golgi apparatus; mildly affects UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase; dbSNP:rs386765812." id="VAR_074207" evidence="30">
<original>T</original>
<variation>M</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs142172397." id="VAR_025417" evidence="5">
<original>A</original>
<variation>G</variation>
<location>
<position position="662"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; no effect on localization to the Golgi; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity toward some substrates; dbSNP:rs281864989." id="VAR_070833" evidence="16 22 29">
<original>K</original>
<variation>N</variation>
<location>
<position position="732"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with mucolipidosis type II or III; unknown pathological significance; no effect on localization to the Golgi; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity toward some substrates; dbSNP:rs144060383." id="VAR_073133" evidence="27 29">
<original>L</original>
<variation>W</variation>
<location>
<position position="785"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on localization to the Golgi; loss of protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281865002." id="VAR_062812" evidence="15 29">
<original>Q</original>
<variation>P</variation>
<location>
<position position="926"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; unknown pathological significance; dbSNP:rs281865003." id="VAR_073134" evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="928"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; abnormal protein cleavage into alpha and beta subunits; no effect on protein abundance; significantly decreased localization to the Golgi; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase." id="VAR_074208" evidence="30">
<location>
<begin position="937"/>
<end position="972"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; unknown pathological significance; no effect on protein abundance; no effect on localization to the Golgi; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs138390866." id="VAR_073135" evidence="16 29">
<original>A</original>
<variation>V</variation>
<location>
<position position="955"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; unknown pathological significance; dbSNP:rs281865005." id="VAR_073136" evidence="14">
<original>H</original>
<variation>R</variation>
<location>
<position position="956"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on protein abundance; no effect on localization to the Golgi; dbSNP:rs281865004." id="VAR_062813" evidence="13 29">
<original>H</original>
<variation>Y</variation>
<location>
<position position="956"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; decreased protein abundance; no effect on localization to the Golgi; no effect on protein cleavage into alpha and beta subunits; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs769587233." id="VAR_070834" evidence="20 25 28 29">
<original>R</original>
<variation>C</variation>
<location>
<position position="986"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; no effect on protein abundance; decreased localization to the Golgi; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281865006." id="VAR_062814" evidence="15 29">
<original>L</original>
<variation>P</variation>
<location>
<position position="1001"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; patients with intermediate phenotype between MLII and MLIIIA; unknown pathological significance; no effect on protein abundance; decreased localization to the Golgi; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281865007." id="VAR_073137" evidence="14 29">
<original>D</original>
<variation>G</variation>
<location>
<position position="1018"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; unknown pathological significance; no effect on localization to the Golgi; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281865010." id="VAR_073138" evidence="16 29">
<original>L</original>
<variation>V</variation>
<location>
<position position="1054"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII." id="VAR_079716" evidence="32">
<location>
<begin position="1111"/>
<end position="1256"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on protein abundance; no effect on localization to the Golgi; loss of UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; dbSNP:rs281865019." id="VAR_062815" evidence="13 29">
<original>N</original>
<variation>S</variation>
<location>
<position position="1153"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; may be a risk factor for stuttering; dbSNP:rs137853825." id="VAR_073221" evidence="18 31">
<original>E</original>
<variation>K</variation>
<location>
<position position="1200"/>
</location>
</feature>
<feature type="sequence variant" description="In MLIIIA; no effect on protein cleavage into alpha and beta subunits; no effect on protein abundance; no effect on subcellular location in cis-Golgi apparatus; slightly affects UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity." id="VAR_074209" evidence="30">
<location>
<position position="1223"/>
</location>
</feature>
<feature type="sequence variant" description="In MLII; decreased protein abundance; no effect on localization to the Golgi; does not suppress protein cleavage into alpha and beta subunits; decreased UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity." id="VAR_027511" evidence="10 25 29">
<original>K</original>
<variation>M</variation>
<location>
<position position="1236"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially cleaved by MBTPS1." evidence="30">
<original>I</original>
<variation>A</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes proteolytic cleavage by MBTPS1." evidence="30">
<original>W</original>
<variation>A</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes proteolytic cleavage by MBTPS1." evidence="19">
<original>R</original>
<variation>A</variation>
<location>
<position position="925"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes proteolytic cleavage by MBTPS1." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="927"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes proteolytic cleavage by MBTPS1." evidence="19">
<original>K</original>
<variation>A</variation>
<location>
<position position="928"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAV98624." ref="2" evidence="34">
<original>I</original>
<variation>V</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAV98624." ref="2" evidence="34">
<original>Q</original>
<variation>L</variation>
<location>
<position position="901"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="138"/>
<end position="141"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="151"/>
<end position="153"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="165"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="175"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="188"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="207"/>
<end position="210"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="225"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="240"/>
<end position="244"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="249"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="252"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="262"/>
<end position="265"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="267"/>
<end position="272"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="274"/>
<end position="280"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2N6D"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00448"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00525"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16094673"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16120602"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16200072"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16465621"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16630736"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16835905"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17034777"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19197337"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19617216"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19634183"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19938078"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19955174"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20147709"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21719679"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22495880"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23566849"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23733939"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23773965"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24045841"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24375680"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24550498"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24767253"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24798265"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25505245"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25788519"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27535533"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28918368"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="1256" mass="143622" checksum="8B861154C516943E" modified="2005-10-11" version="1" precursor="true">
MLFKLLQRQTYTCLSHRYGLYVCFLGVVVTIVSAFQFGEVVLEWSRDQYHVLFDSYRDNI
AGKSFQNRLCLPMPIDVVYTWVNGTDLELLKELQQVREQMEEEQKAMREILGKNTTEPTK
KSEKQLECLLTHCIKVPMLVLDPALPANITLKDLPSLYPSFHSASDIFNVAKPKNPSTNV
SVVVFDSTKDVEDAHSGLLKGNSRQTVWRGYLTTDKEVPGLVLMQDLAFLSGFPPTFKET
NQLKTKLPENLSSKVKLLQLYSEASVALLKLNNPKDFQELNKQTKKNMTIDGKELTISPA
YLLWDLSAISQSKQDEDISASRFEDNEELRYSLRSIERHAPWVRNIFIVTNGQIPSWLNL
DNPRVTIVTHQDVFRNLSHLPTFSSPAIESHIHRIEGLSQKFIYLNDDVMFGKDVWPDDF
YSHSKGQKVYLTWPVPNCAEGCPGSWIKDGYCDKACNNSACDWDGGDCSGNSGGSRYIAG
GGGTGSIGVGQPWQFGGGINSVSYCNQGCANSWLADKFCDQACNVLSCGFDAGDCGQDHF
HELYKVILLPNQTHYIIPKGECLPYFSFAEVAKRGVEGAYSDNPIIRHASIANKWKTIHL
IMHSGMNATTIHFNLTFQNTNDEEFKMQITVEVDTREGPKLNSTAQKGYENLVSPITLLP
EAEILFEDIPKEKRFPKFKRHDVNSTRRAQEEVKIPLVNISLLPKDAQLSLNTLDLQLEH
GDITLKGYNLSKSALLRSFLMNSQHAKIKNQAIITDETNDSLVAPQEKQVHKSILPNSLG
VSERLQRLTFPAVSVKVNGHDQGQNPPLDLETTARFRVETHTQKTIGGNVTKEKPPSLIV
PLESQMTKEKKITGKEKENSRMEENAENHIGVTEVLLGRKLQHYTDSYLGFLPWEKKKYF
QDLLDEEESLKTQLAYFTDSKNTGRQLKDTFADSLRYVNKILNSKFGFTSRKVPAHMPHM
IDRIVMQELQDMFPEEFDKTSFHKVRHSEDMQFAFSYFYYLMSAVQPLNISQVFDEVDTD
QSGVLSDREIRTLATRIHELPLSLQDLTGLEHMLINCSKMLPADITQLNNIPPTQESYYD
PNLPPVTKSLVTNCKPVTDKIHKAYKDKNKYRFEIMGEEEIAFKMIRTNVSHVVGQLDDI
RKNPRKFVCLNDNIDHNHKDAQTVKAVLRDFYESMFPIPSQFELPREYRNRFLHMHELQE
WRAYRDKLKFWTHCVLATLIMFTIFSFFAEQLIALKRKIFPRRRIHKEASPNRIRV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>